Ali Ünal

4.3k total citations
125 papers, 2.1k citations indexed

About

Ali Ünal is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Ali Ünal has authored 125 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Hematology, 30 papers in Genetics and 28 papers in Oncology. Recurrent topics in Ali Ünal's work include Hematopoietic Stem Cell Transplantation (29 papers), Multiple Myeloma Research and Treatments (14 papers) and Acute Myeloid Leukemia Research (13 papers). Ali Ünal is often cited by papers focused on Hematopoietic Stem Cell Transplantation (29 papers), Multiple Myeloma Research and Treatments (14 papers) and Acute Myeloid Leukemia Research (13 papers). Ali Ünal collaborates with scholars based in Türkiye, France and Italy. Ali Ünal's co-authors include Bülent Eser, Mustafa Çetın, Özlem Er, Mustafa Altınbaş, Leylagül Kaynar, Metin Özkan, Serdar Soyuer, H.Ş. Çoşkun, Fevzi Altuntaş and İ̇smail Sarı and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ali Ünal

116 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Ünal Türkiye 23 835 389 369 322 292 125 2.1k
Aaron S. Rosenberg United States 24 458 0.5× 221 0.6× 438 1.2× 694 2.2× 229 0.8× 87 1.9k
J. Mark Sloan United States 27 510 0.6× 522 1.3× 529 1.4× 209 0.6× 387 1.3× 143 2.4k
Silvio Antoniak United States 30 986 1.2× 274 0.7× 201 0.5× 478 1.5× 250 0.9× 66 2.5k
Peter A. von dem Borne Netherlands 26 1.4k 1.7× 543 1.4× 333 0.9× 482 1.5× 84 0.3× 96 2.4k
Rolf T. Urbanus Netherlands 34 2.0k 2.4× 284 0.7× 124 0.3× 811 2.5× 367 1.3× 126 3.9k
Lynne Uhl United States 23 829 1.0× 267 0.7× 327 0.9× 861 2.7× 375 1.3× 69 2.2k
F Forestier France 26 949 1.1× 207 0.5× 171 0.5× 440 1.4× 294 1.0× 97 3.0k
D. C. Heaton New Zealand 20 572 0.7× 294 0.8× 133 0.4× 161 0.5× 149 0.5× 45 1.3k
W. Keith Hoots United States 34 2.5k 3.0× 574 1.5× 196 0.5× 324 1.0× 377 1.3× 97 4.2k
Mark Weinstein United States 25 2.0k 2.4× 473 1.2× 277 0.8× 933 2.9× 741 2.5× 53 3.8k

Countries citing papers authored by Ali Ünal

Since Specialization
Citations

This map shows the geographic impact of Ali Ünal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Ünal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Ünal more than expected).

Fields of papers citing papers by Ali Ünal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Ünal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Ünal. The network helps show where Ali Ünal may publish in the future.

Co-authorship network of co-authors of Ali Ünal

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Ünal. A scholar is included among the top collaborators of Ali Ünal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Ünal. Ali Ünal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ünal, Ali, et al.. (2024). AUTOLOGOUS STEM CELL TRANSPLANTATION EXPERIENCE IN B-ALL DEVELOPING DURING MAINTENANCE LENALIDOMIDE TREATMENT:CASE REPORT. Hematology Transfusion and Cell Therapy. 46. 8–9. 1 indexed citations
2.
Keklık, Muzaffer, et al.. (2024). CLL-232 Chronic Lymphocytic Leukemia: Immune Dysregulation and Management: A Case Report. Clinical Lymphoma Myeloma & Leukemia. 24. S348–S348.
3.
Keklık, Muzaffer, et al.. (2024). FLUDARABINE-INDUCED BRADYCARDIA IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION. Hematology Transfusion and Cell Therapy. 46. 6–6. 1 indexed citations
4.
Keklık, Muzaffer, et al.. (2024). Uric Acid Levels Might be A Prognostic Indicator For Survival in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation. Single-Center Experience. Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi.
5.
Keklık, Muzaffer, et al.. (2023). Coronavirus Anxiety Level and COVID-19 Vaccine Attitude Among Patients With Hematological Malignancies. Cureus. 15(5). e38618–e38618. 1 indexed citations
6.
Akkuş, Erman, Yıldız Aydın, Sevgi Kalayoğlu Beşışık, et al.. (2023). Germline genetic variants in Turkish familial multiple myeloma/monoclonal gammopathy of undetermined significance cases. British Journal of Haematology. 204(3). 931–938. 3 indexed citations
8.
Saydam, Güray, Rıdvan Ali, Ahmet Muzaffer Demir, et al.. (2022). The Effect of Comorbidities on the Choice of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia. PubMed. 11(1). IJH38–IJH38. 11 indexed citations
9.
Gilleece, Maria, Avichai Shimoni, Myriam Labopin, et al.. (2021). Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT. Blood Cancer Journal. 11(5). 88–88. 18 indexed citations
10.
Yeral, Mahmut, Can Boğa, Ali Ünal, et al.. (2020). A Comparison of the BEAM and MITO/MEL Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma: An Analysis of Efficiency and Treatment-Related Toxicity. Clinical Lymphoma Myeloma & Leukemia. 20(10). 652–660. 4 indexed citations
12.
Keklık, Muzaffer, Serdar Şıvgın, Kemal Denız, et al.. (2013). Coincidence of three solid tumors in a patient with multiple myeloma. Chinese Medical Journal. 126(6). 1186–1187. 2 indexed citations
13.
Baldane, Süleyman, Muzaffer Keklık, Leylagül Kaynar, et al.. (2013). The Impact of Pretransplant Hypoalbuminemia on Survival in patients With Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Nutritional Problem?. Transplantation Proceedings. 45(9). 3371–3374. 11 indexed citations
14.
Şıvgın, Serdar, Bülent Eser, Leylagül Kaynar, et al.. (2013). Encephalitozoon intestinalis: A Rare Cause of Diarrhea in an Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Recipient Complicated by Albendazole-Related Hepatotoxicity. SHILAP Revista de lepidopterología. 30(2). 204–208. 5 indexed citations
15.
Baldane, Süleyman, Leylagül Kaynar, Fatih Kurnaz, et al.. (2011). Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation. Neoplasma. 59(2). 183–190. 25 indexed citations
16.
Kaynar, Leylagül, Fevzi Altuntaş, Ismet Aydogdu, et al.. (2008). Therapeutic plasma exchange in patients with neurologic diseases: Retrospective multicenter study. Transfusion and Apheresis Science. 38(2). 109–115. 48 indexed citations
17.
Eser, Bülent, Muhammet Güven, Ali Ünal, et al.. (2005). The Role of Plasma Exchange in HELLP Syndrome. Clinical and Applied Thrombosis/Hemostasis. 11(2). 211–217. 61 indexed citations
18.
Abacı, Adnan, Mustafa Çalışkan, Fahrı Bayram, et al.. (2005). A new definition of aspirin non-responsiveness by Platelet Function Analyzer-100™ and its predictors. Platelets. 17(1). 7–13. 20 indexed citations
19.
Er, Özlem, H.Ş. Çoşkun, Mustafa Altınbaş, et al.. (2004). Meropenem +/− Granulocyte Colony Stimulating Factor in the Treatment of Febrile Neutropenic Patients with Cancer: Prospective Randomized Study. Journal of Chemotherapy. 16(3). 288–292. 1 indexed citations
20.
Altınbaş, Mustafa, H.Ş. Çoşkun, Özlem Er, et al.. (2004). A randomized clinical trial of combination chemotherapy with and without low‐molecular‐weight heparin in small cell lung cancer. Journal of Thrombosis and Haemostasis. 2(8). 1266–1271. 367 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026